Cargando…

Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins

Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kramer, Bart, de Haan, Luuk, Vermeer, Marjolein, Olivier, Thomas, Hankemeier, Thomas, Vulto, Paul, Joore, Jos, Lanz, Henriëtte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770899/
https://www.ncbi.nlm.nih.gov/pubmed/31546820
http://dx.doi.org/10.3390/ijms20184647
_version_ 1783455590962429952
author Kramer, Bart
de Haan, Luuk
Vermeer, Marjolein
Olivier, Thomas
Hankemeier, Thomas
Vulto, Paul
Joore, Jos
Lanz, Henriëtte L.
author_facet Kramer, Bart
de Haan, Luuk
Vermeer, Marjolein
Olivier, Thomas
Hankemeier, Thomas
Vulto, Paul
Joore, Jos
Lanz, Henriëtte L.
author_sort Kramer, Bart
collection PubMed
description Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here, we demonstrated a 3D microfluidic interstitial flow model to mimic the intratumoral pressure in PDAC. We found that subjecting the S2-028 PDAC cell line to interstitial flow inhibits the proliferation, while maintaining a high viability. We observed increased gemcitabine chemoresistance, with an almost nine-fold higher EC50 as compared to a monolayer culture (31 nM versus 277 nM), and an alleviated expression and function of the multidrug resistance protein (MRP) family. In conclusion, we developed a 3D cell culture modality for studying intratissue pressure and flow that exhibits more predictive capabilities than conventional 2D cell culture and is less time-consuming, and more scalable and accessible than animal models. This increase in microphysiological relevance might support improved efficiency in the drug development pipeline.
format Online
Article
Text
id pubmed-6770899
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67708992019-10-30 Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins Kramer, Bart de Haan, Luuk Vermeer, Marjolein Olivier, Thomas Hankemeier, Thomas Vulto, Paul Joore, Jos Lanz, Henriëtte L. Int J Mol Sci Article Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal cancers due to a high chemoresistance and poor vascularization, which results in an ineffective systemic therapy. PDAC is characterized by a high intratumoral pressure, which is not captured by current 2D and 3D in vitro models. Here, we demonstrated a 3D microfluidic interstitial flow model to mimic the intratumoral pressure in PDAC. We found that subjecting the S2-028 PDAC cell line to interstitial flow inhibits the proliferation, while maintaining a high viability. We observed increased gemcitabine chemoresistance, with an almost nine-fold higher EC50 as compared to a monolayer culture (31 nM versus 277 nM), and an alleviated expression and function of the multidrug resistance protein (MRP) family. In conclusion, we developed a 3D cell culture modality for studying intratissue pressure and flow that exhibits more predictive capabilities than conventional 2D cell culture and is less time-consuming, and more scalable and accessible than animal models. This increase in microphysiological relevance might support improved efficiency in the drug development pipeline. MDPI 2019-09-19 /pmc/articles/PMC6770899/ /pubmed/31546820 http://dx.doi.org/10.3390/ijms20184647 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kramer, Bart
de Haan, Luuk
Vermeer, Marjolein
Olivier, Thomas
Hankemeier, Thomas
Vulto, Paul
Joore, Jos
Lanz, Henriëtte L.
Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
title Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
title_full Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
title_fullStr Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
title_full_unstemmed Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
title_short Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins
title_sort interstitial flow recapitulates gemcitabine chemoresistance in a 3d microfluidic pancreatic ductal adenocarcinoma model by induction of multidrug resistance proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770899/
https://www.ncbi.nlm.nih.gov/pubmed/31546820
http://dx.doi.org/10.3390/ijms20184647
work_keys_str_mv AT kramerbart interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT dehaanluuk interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT vermeermarjolein interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT olivierthomas interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT hankemeierthomas interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT vultopaul interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT joorejos interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins
AT lanzhenriettel interstitialflowrecapitulatesgemcitabinechemoresistanceina3dmicrofluidicpancreaticductaladenocarcinomamodelbyinductionofmultidrugresistanceproteins